Efficacy and safety of HERG channel agonists for treatment of Long QT Syndrome type 8

Back

ESC Professional Premium Access

Efficacy and safety of HERG channel agonists for treatment of Long QT Syndrome type 8

Session: Novel insights into arrhythmias

Topic: Arrhythmias

Speaker: Doctor D. Kukavica (Pavia, IT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Deni Kukavica

ICS Maugeri - IRCCS Pavia, Pavia (Italy)

0 follower

8 more presentations in this session

Characterisation of the novel SCN5A-P1891A variant, implicated in left ventricular noncompaction cardiomyopathy in a Finnish family, using human induced pluripotent stem cell-derived cardiomyocytes.

Speaker: Doctor Q. Majid (Helsinki, FI)

Advancing cardiac 3D organoid-on-chip: integrating iPSC-derived MELAS syndrome models to study electromechanical synchronicity and cardiac memory using contactless technology

Speaker: Associate Professor M. Miragoli (Parma, IT)

Investigating the role of WT1 in Brugada syndrome pathophysiology

Speaker: Ms M. Marsman (Amsterdam, NL)

Computational modeling of cardiac electrophysiology applied to a swine model of Long QT Syndrome

Speaker: Doctor A. Trancuccio (Pavia, IT)

Indoxyl sulfate deteriorates cardiac electrophysiological function and increases the likelihood of arrhythmias in human ventricular myocardial cells

Speaker: Mr O. Pfeuffer (Regensburg, DE)

Access the full session

Novel insights into arrhythmias

Speakers: Doctor D. Kukavica, Doctor Q. Majid, Associate Professor M. Miragoli, Ms M. Marsman, Doctor A. Trancuccio...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources